Literature DB >> 23646005

Epilepsy associated with systemic autoimmune disorders.

Orrin Devinsky1, Adam Schein, Souhel Najjar.   

Abstract

Systemic autoimmune disorders affect multiple organ systems. Brain involvement commonly causes seizures, which may be the presenting symptom. Systemic lupus erythematosus, Sjorgren's syndrome, Wegener's granulomatosis, sarcoidsosis, celiac disease, Crohn's disease, Behcet's, and Hashimoto's encephalopathy are reviewed. Mechanisms underlying CNS pathology in systemic autoimmune disorders-and specifically factors predisposing these patients-are discussed, including vascular disease (e.g., prothrombotic state, anticardiolipin antibody, emboli, vasculitis), antineuronal antibodies, immune complexes, cytokines, metabolic disorders, infection, and therapy. Diagnostic and therapeutic strategies must be individualized for both the disorder and the patient. Systemic autoimmune disorders affect multiple organ systems and frequently involve the central and peripheral nervous systems. Seizures are among the most common neurological manifestation and occasionally can be the presenting symptom. There are many causes of seizures in systemic autoimmune disorders (Table 1), and the first clinical challenge is to determine not only the cause but also the significance of seizures. In some cases, they are clues to metabolic or infectious disorders or medication toxicity; in other cases, seizures herald a life-threatening progression of the underlying illness.

Entities:  

Year:  2013        PMID: 23646005      PMCID: PMC3639560          DOI: 10.5698/1535-7597-13.2.62

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN: 1535-7511            Impact factor:   7.500


  84 in total

1.  Prevalence and patterns of neurological involvement in Behcet's disease: a prospective study from Iraq.

Authors:  A Al-Araji; K Sharquie; Z Al-Rawi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

2.  Seizures, cognitive abnormalities, and abnormal magnetic resonance imaging findings in a 19-year-old woman.

Authors:  Tanya Mayer; Orrin Devinsky
Journal:  Rev Neurol Dis       Date:  2006

3.  Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I.

Authors:  Armin Alaedini; Haruka Okamoto; Chiara Briani; Kurt Wollenberg; Holly A Shill; Khalafalla O Bushara; Howard W Sander; Peter H R Green; Mark Hallett; Norman Latov
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

4.  Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group.

Authors:  G Akman-Demir; P Serdaroglu; B Tasçi
Journal:  Brain       Date:  1999-11       Impact factor: 13.501

5.  Hashimoto's disease and encephalopathy.

Authors:  L Brain; E H Jellinek; K Ball
Journal:  Lancet       Date:  1966-09-03       Impact factor: 79.321

Review 6.  Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study.

Authors:  H H Yu; J H Lee; L C Wang; Y H Yang; B L Chiang
Journal:  Lupus       Date:  2006       Impact factor: 2.911

7.  Hashimoto's encephalopathy: documentation of mesial temporal seizure origin by ictal EEG.

Authors:  A Arain; B Abou-Khalil; H Moses
Journal:  Seizure       Date:  2001-09       Impact factor: 3.184

Review 8.  Hashimoto's encephalopathy.

Authors:  Nicoline Schiess; Carlos A Pardo
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

9.  Clinical description of seizures in patients with systemic lupus erythematosus.

Authors:  Alejandra González-Duarte; Carlos Gerardo Cantú-Brito; Luis Ruano-Calderón; Guillermo García-Ramos
Journal:  Eur Neurol       Date:  2008-04-11       Impact factor: 1.710

10.  Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients.

Authors:  S Malik; G R Bruner; C Williams-Weese; L Feo; R Hal Scofield; M Reichlin; J B Harley; A H Sawalha
Journal:  Lupus       Date:  2007       Impact factor: 2.911

View more
  16 in total

Review 1.  Deep Belief Networks for Electroencephalography: A Review of Recent Contributions and Future Outlooks.

Authors:  Faezeh Movahedi; James L Coyle; Ervin Sejdic
Journal:  IEEE J Biomed Health Inform       Date:  2017-07-14       Impact factor: 5.772

Review 2.  Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approaches.

Authors:  Giovanna Vitaliti; Piero Pavone; Fahad Mahmood; Giuseppe Nunnari; Raffaele Falsaperla
Journal:  Hum Vaccin Immunother       Date:  2014-03-07       Impact factor: 3.452

3.  Neurological Manifestations in Systemic Lupus Erythematosus: A Single Centre Study from North East India.

Authors:  Sanjeeb Kakati; Bhupen Barman; Sobur U Ahmed; Masaraf Hussain
Journal:  J Clin Diagn Res       Date:  2017-01-01

4.  An Integrated Multi-Omic Network Analysis Identifies Seizure-Associated Dysregulated Pathways in the GAERS Model of Absence Epilepsy.

Authors:  Anna Harutyunyan; Debbie Chong; Rui Li; Anup D Shah; Zahra Ali; Cheng Huang; Christopher K Barlow; Piero Perucca; Terence J O'Brien; Nigel C Jones; Ralf B Schittenhelm; Alison Anderson; Pablo M Casillas-Espinosa
Journal:  Int J Mol Sci       Date:  2022-05-28       Impact factor: 6.208

Review 5.  Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): case report of reversible coma and status epilepticus in an adolescent patient and review of the literature.

Authors:  Johannes M Hilberath; Heinrich Schmidt; Gerhard K Wolf
Journal:  Eur J Pediatr       Date:  2014-08-02       Impact factor: 3.183

6.  Parental rheumatoid arthritis and childhood epilepsy: A nationwide cohort study.

Authors:  Ane Lilleøre Rom; Chun Sen Wu; Jørn Olsen; Damini Jawaheer; Merete Lund Hetland; Jakob Christensen; Bent Ottesen; Lina Steinrud Mørch
Journal:  Neurology       Date:  2016-11-16       Impact factor: 9.910

Review 7.  Neurological Complications in Patients with Systemic Lupus Erythematosus.

Authors:  Amir Shaban; Enrique C Leira
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 6.030

8.  Indomethacin can downregulate the levels of inflammatory mediators in the hippocampus of rats submitted to pilocarpine-induced status epilepticus.

Authors:  Michele Juliane Vieira; Sandra Regina Perosa; Gustavo Adolfo Argaãaraz; José Antônio Silva; Esper Abrão Cavalheiro; Maria da Graça Naffah-Mazzacoratti
Journal:  Clinics (Sao Paulo)       Date:  2014-09       Impact factor: 2.365

9.  Association of epilepsy and asthma: a population-based retrospective cohort study.

Authors:  Kuo-Liang Chiang; Jen-Yu Lee; Fang-Chuan Kuo; Chin-Yin Huang
Journal:  PeerJ       Date:  2018-05-18       Impact factor: 2.984

Review 10.  Antibody-associated epilepsies: Clinical features, evidence for immunotherapies and future research questions.

Authors:  Ochuko D Bakpa; Markus Reuber; Sarosh R Irani
Journal:  Seizure       Date:  2016-07-15       Impact factor: 3.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.